knowledge -WSS

knowledge

author：leisure time 2025-09-30 16:26:19 - browse：4425

Adam's take main illustration — Molly Ferguson/STAT

It took Anavex Life Sciences seven months to finally acknowledge the failure of a late-stage clinical trial in Rett syndrome.

The negative study outcome was never in doubt, so the only surprise from Tuesday’s announcement was the company’s lame attempt at damage control. Anavex is a serial dissembler of clinical trial results, so I was expecting better spin. Instead, management barely tried, which tells you the real results from the Rett study must be truly awful.

Anavex shares fell 31% to $6 in early trading. The company’s only drug in clinical development, called blarcamesine, is a zero. Rett is the latest failure, following earlier study failures in Alzheimer’s disease and Parkinson’s disease. Yet even with Tuesday’s drop in share price, Anavex still carries a fully diluted market value of nearly $650 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

WSS

Weight bias in eating disorder treatment complicated by new weight loss drugs

FAMU bans football players from facility after release of rap video shot in team's locker room

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

With FDA staff opposed to Sarepta therapy, top official intervened

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

leisure time

knowledge

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Colonoscopy at 40? Study finds a possible benefit

How to save PrEP access — and even expand it

Gene therapy has helped boys walk. Can scientists keep it that way?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

3 hurdles to bringing medical devices to the U.S. market

United colonoscopy coverage change 'may cost lives,' doctors say

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

focus

Thousands protest mob assault of women who were paraded naked in remote Indian border state

STAT's guide to the next generation of CAR

WATCH: Why do fingernails fall off when they're damaged?

Statins reduce cardiovascular risk in people living with HIV

Paxlovid study fails to answer questions over benefit for broader groups

Ask STAT: What do you want to know about ChatGPT in medicine?

focus

focus

explore

focus